A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment

Name: A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment
Published: 2023
License: Public Domain

Takeda · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

drug-therapy

plaque psoriasis, drug therapy, latitude psoriasis 1, latitude research program, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment

Related documents